Opportunity Information: Apply for PAR 18 030

The NIA Revision and Resubmission Program Project Applications opportunity (Funding Opportunity Number PAR 18 030) is a National Institutes of Health discretionary grant program run by the National Institute on Aging (NIA) under CFDA 93.866. It is focused on Program Project (P01) applications and is designed specifically for two situations: (1) revision applications to program project awards that are already funded by NIA, and (2) resubmissions of program project applications that were previously submitted but not funded, including resubmissions of unfunded revision requests. In plain terms, this announcement is meant to help research teams either expand an existing NIA-funded P01 program in a structured way or improve and resubmit a previously unsuccessful P01 application so it can be reconsidered.

A key expectation is that proposed work must align with NIA's mission areas, meaning the scientific focus should be relevant to aging and age-related health and disease. For revision requests in particular, the application is expected to go beyond simply continuing what is already funded. The revision should add something new: either an expansion of one or more existing projects within the larger P01, or the creation of one or more entirely new projects that fit coherently within the program project framework. The idea is that the parent P01 remains the foundation, but the revision introduces additional, mission-relevant science that strengthens or broadens the overall program.

There is also an important timing and budget boundary for revisions: a revision application cannot extend the project period beyond the end date of the currently funded parent P01 award. So even if the new or expanded work is substantial, the request has to fit within the remaining time window of the active P01. That condition is central to how these revisions are planned, since applicants must scale the proposed added work to what can realistically be completed and managed before the parent award ends.

The funding instrument is a grant, and the activity category is health. The announcement is described as "P01 Clinical Trial Optional," which indicates that clinical trials may be included when appropriate, but they are not required. Applicants would still need to follow NIH rules and the specific FOA instructions regarding human subjects research and clinical trial definitions if they propose clinical trial activities, but the core point is flexibility: the P01 can be clinical-trial oriented or not, depending on the science.

Eligibility is broad and includes many typical NIH-eligible organizations. Eligible applicant types listed include state, county, city or township governments; special district governments; independent school districts; public housing authorities/Indian housing authorities; public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); small businesses; and Native American tribal governments (federally recognized) as well as tribal organizations other than federally recognized tribal governments. The announcement also explicitly highlights additional categories of eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions. Practically, this signals NIA's openness to applications from a wide range of institutional settings, including organizations that are often underrepresented in major research funding portfolios.

Foreign involvement is allowed only in a limited, specific way. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. However, "foreign components" as defined by the NIH Grants Policy Statement are allowed. That usually means a U.S.-based applicant can include certain scientifically justified international elements (such as collaborations, data collection sites, or other project components abroad) as part of the overall program, as long as they meet NIH policy requirements and are properly described and approved.

From the administrative details provided, the original closing date listed is 2019-07-12 and the creation date is 2017-10-30. The award ceiling and expected number of awards are not specified in the provided source text, which implies applicants would need to refer to the full FOA and NIH budget guidance for the P01 mechanism to understand typical funding levels, budgeting conventions, and constraints. Overall, the opportunity is best understood as a pathway for NIA-supported P01 teams to add new mission-relevant scientific work within the remaining life of an active program project, and for investigators with unfunded P01 submissions (or unfunded revisions) to revise their approach and come back with a stronger resubmission for NIA consideration.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIA Revision and Resubmission Program Project Applications (P01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2017-10-30.
  • Applicants must submit their applications by 2019-07-12. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 18 030

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Optional)

Previous opportunity: Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 18 030

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 18 030) also looked into and applied for these:

Funding Opportunity
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11-Clinical Trial Not Allowed) Apply for PAR 18 335

Funding Number: PAR 18 335
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Phenotypic and Functional Studies on FOXO3 Human Longevity Variants to Inform Potential Therapeutic Target Identification Research (R01 Clinical Trial Optional) Apply for PAR 18 026

Funding Number: PAR 18 026
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) Apply for PAR 18 296

Funding Number: PAR 18 296
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIA Program Project Applications (P01 Clinical Trial Optional) Apply for PAR 18 297

Funding Number: PAR 18 297
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
93.067 Apply for CDC RFA GH13 1368A

Funding Number: CDC RFA GH13 1368A
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Program for Extramural/Intramural Alcohol Research Collaborations (U01 Clinical Trial Optional) Apply for PAR 18 195

Funding Number: PAR 18 195
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Increasing the Use of Medications for the Treatment of Alcohol Use Disorders (R01 Clinical Trial Optional) Apply for PAR 18 196

Funding Number: PAR 18 196
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R21/R33 Clinical Trial Optional) Apply for PAR 18 181

Funding Number: PAR 18 181
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alcohol Impairment of Immune Function, Host Defense and Tissue Homeostasis (R01 Clinical Trial Optional) Apply for PA 18 191

Funding Number: PA 18 191
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Revision Applications for Validation of Mobile/Wireless Health Tools for Measurement and Intervention (R01) (Clinical Trials Not Allowed) Apply for PA 18 338

Funding Number: PA 18 338
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Phased Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R61/R33 Clinical Trial Required) Apply for PAR 18 114

Funding Number: PAR 18 114
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Improving Outcomes for Disorders of Human Communication (R01 Clinical Trial Optional) Apply for PA 18 287

Funding Number: PA 18 287
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Minority HIV/AIDS Research Initiative (MARI) to Build HIV Prevention, Treatment and Research Capacity in Disproportionately Affected Black and Hispanic Communities and Among Historically Underrepresented Researchers Apply for RFA PS 16 00103CONT18

Funding Number: RFA PS 16 00103CONT18
Agency: Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: Case Dependent
Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R33 Clinical Trial Required) Apply for PAR 18 115

Funding Number: PAR 18 115
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Emerging Infectious Sentinel Networks (EISN) Research Apply for RFA CK 16 00103CONT18

Funding Number: RFA CK 16 00103CONT18
Agency: Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: Case Dependent
NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 18 118

Funding Number: PAR 18 118
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Improving Outcomes for Disorders of Human Communication (R21 Clinical Trial Optional) Apply for PA 18 288

Funding Number: PA 18 288
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Population-based HIV Impact Assessments in Resource-Constrained Settings under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH14 1409A

Funding Number: CDC RFA GH14 1409A
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R03 Clinical Trial Required) Apply for PA 18 198

Funding Number: PA 18 198
Agency: National Institutes of Health
Category: Health
Funding Amount: $50,000
Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R21 Clinical Trial Required) Apply for PA 18 197

Funding Number: PA 18 197
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 030", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: